Search the Newsreel

Lithium Argentina AG

Lithium Argentina AG announced its second-quarter 2026 results, reporting a net income of $27 million, down from $49 million in the first quarter of 2026. Adjusted EBITDA for the quarter was $110 million, with higher realized prices compensating for lower sales volumes. The company's …

Lithium Americas (Argentina) (NYSE:LAR) Shares Gap Down After Earnings Miss

Q2 2026 Lithium Argentina AG Earnings Call Transcript

Argent BioPharma (ASX:RGT) Expands CannEpil® Development Strategy with U.S. Veterinary Programme

argenx (ENXTBR:ARGX) Stock Looks Fully Valued Despite Strong Returns And Deal Hopes

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. argenx stock has delivered a strong long term return over the past five years, yet the current valuation checks and recent acquisition plans raise questions about how …

Earnings Flash (LAR) Lithium Argentina Posts Q2 EPS $0.01

Lithium Argentina Q2 2026 profit falls as company cites US$ 38 million deferred tax charge at Cauchari-Olaroz JV

Lithium Argentina reported a net income of US$ 1.3 million in Q2 2026, significantly impacted by a US$ 38.1 million non-cash deferred tax charge at its Cauchari-Olaroz joint venture. The company's equity-accounted profit from Cauchari-Olaroz was US$ 12.3 million, with the JV generating US$ …

Lithium Americas: Q2 Earnings Snapshot

Telecom Argentina S.A. 2026 Q2 - Results - Earnings Call Presentation (NYSE:TEO) 2026-08-11

Lithium Argentina AG 2026 Q2 - Results - Earnings Call Presentation (TSX:LAR:CA) 2026-08-11

This article presents the slide deck published by Lithium Argentina AG in conjunction with their Q2 2026 earnings call. It highlights the company's financial results and provides insights into their performance during the second quarter of 2026 for investors and analysts. The content originates …

Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMAD.BA) stock price, news, quote and history

This article provides financial information for Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMAD.BA), including its stock price, news, quotes, and historical data. As of August 11, the stock closed at 2.0500 USD, experiencing a -4.21% change. The performance overview shows the company's trailing …

Banco Bilbao Vizcaya Argentaria SA (BBVA) Earnings Forecast: Future EPS & Revenue Growth Estimates

RBC Capital Reaffirms Their Hold Rating on Banco Bilbao Vizcaya Argentaria (BVA)

RBC Capital analyst Benjamin Toms has reiterated a Hold rating on Banco Bilbao Vizcaya Argentaria (BVA), setting a price target of €24.00. While Deutsche Bank also issued a Hold rating, Goldman Sachs maintained a Buy rating on the stock. Insider sentiment for BVA is …

Repligen Corporation (NASDAQ:RGEN) Given Average Rating of "Moderate Buy" by Brokerages

Repligen Corporation (NASDAQ:RGEN) has received a "Moderate Buy" consensus rating from eighteen brokerages, with an average 12-month price target of $166.43. The company recently surpassed quarterly earnings and revenue expectations, reporting $0.54 EPS and $204.13 million in revenue, an 11.9% year-over-year increase. Despite a …

Emergent BioSolutions cuts FY2026 revenue forecast, triggering securities investigation.

Emergent BioSolutions has significantly lowered its FY2026 revenue guidance, leading to a sharp decline in its stock price and a securities investigation by Levi & Korsinsky. The law firm is examining whether the company's prior optimistic forecasts were misleading, encouraging investors who suffered losses …

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Levi & Korsinsky, LLP is investigating Emergent BioSolutions (EBS) for potential securities law violations after the company significantly cut its FY2026 revenue guidance. The firm encourages investors who lost money on EBS shares to submit their loss information for a free evaluation of their …

argenx (ENXTBR:ARGX) Is Considering A Forte Biosciences Acquisition

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. argenx (ENXTBR:ARGX) is set to consider and discuss the acquisition of Forte Biosciences, Inc. The potential deal would expand argenx's reach in biopharmaceutical …

Transcript : Telecom Argentina S.A., Q2 2026 Earnings Call, Aug 10, 2026

Telecom Argentina (NYSE: TEO) swings to ARS 869,038M profit on rising revenue

Repligen Shares Surge 16.2% as Record Revenue Offsets Shrinking Q2 Margins

Lithium Argentina (LAR) Q2 Earnings Preview: Market Pricing High Growth Despite Unprofitability

Telecom Argentina: EBITDA margin, revenues, and free cash flow surged, driven by network expansion and ARPU growth

Telecom Argentina reported a significant increase in its EBITDA margin to 35.8% in the first half of 2026, with revenues climbing 23% year-over-year. This growth was fueled by strong service revenues, ARPU improvement, and accelerated network investments in 5G and FTTH. The company also …

Loma Negra (LOMA) Stock Could Be 49% Overvalued As Cash Flow Lags

Loma Negra (LOMA) has seen a strong 83.6% share price gain over the past five years, but its current price of US$10.44 suggests it is significantly overvalued. Both Discounted Cash Flow (DCF) analysis and P/E ratio comparisons indicate the stock trades at a premium, …

H.C. Wainwright cuts Emergent BioSolutions stock price target on revenue outlook

H.C. Wainwright has reduced its price target for Emergent BioSolutions (NYSE:EBS) to $10 from $12, while maintaining a Buy rating, due to a lowered full-year 2026 revenue guidance. The company's NARCAN sales have declined significantly due to new competition in the naloxone market, despite …

RBC ajusta su modelo para BBVA tras los resultados del segundo trimestre; mantiene la calificación de "Rendimiento en línea con el sector".

Repligen Corporation (RGEN) Stock Analysis: A Healthcare Standout with 13.3% Potential Upside

Repligen Corporation (RGEN) is analyzed as a strong player in the healthcare sector, specifically medical instruments and supplies, with a current market cap of $9.25 billion and a potential upside of 13.3% according to analysts. The company shows promising revenue growth, positive analyst sentiment …

Price to earnings forward of NRGENE TECHNOLOGIES LTD – TASE:NRGN

Banco Bbva Argentina SA (BBAR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Telecom Argentina SA (TEO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Repligen (RGEN) Is Up 16.2% After Revenue Rises But Profitability Compresses In Q2 2026

In July 2026, Repligen Corporation reported second-quarter 2026 results showing revenue of US$204.13 million versus US$182.37 million a year earlier, while net income fell to US$5.01 million from US$14.87 million and diluted EPS from continuing operations decreased to US$0.09 from US$0.26. Over the six-month …

Repligen (RGEN) Could Be 10% Below Fair Value On Mixed Q2 Earnings

Repligen (RGEN) recently reported mixed Q2 2026 earnings, showing higher revenue but lower net income and EPS year-over-year. Despite this, the stock has seen strong recent momentum, with a 90-day return of 41.4% and a 1-year return of 47.09%, positioning it about 10% below …

Emergent BioSolutions Inc (EBS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Telecom Argentina ADR earnings missed by $0.05, revenue fell short of estimates

Telecom Argentina ADR (NYSE: TEO) reported second-quarter EPS of $0.216, missing analyst estimates by $0.05, and revenue of $1.72 billion, falling short of the $1.73 billion consensus. Despite the miss, the company's stock has seen positive performance, rising 18.310% in the last three months …

Loma Negra Compania Industrial Argentina (NYSE:LOMA) Releases Earnings Results, Misses Expectations By $0.06 EPS

Telecom Argentina Stet - France Telecom (NYSE:TEO) Issues Earnings Results, Beats Expectations By $0.11 EPS

Telecom Argentina Stet - France Telecom (NYSE:TEO) reported quarterly earnings of $0.36 per share, exceeding analyst expectations by $0.11, with revenue matching estimates at $1.72 billion. Shares rose 0.3% to $13.85, and several analysts have upgraded the stock or raised price targets. Insider buying …

Is Repligen’s (RGEN) Rising Revenue But Softer Earnings Rewriting Its Profitability Story?

Repligen Corporation (RGEN) reported rising revenue in Q2 2026, reaching US$204.13 million, but net income and earnings per share fell compared to the previous year. This performance highlights a conflict between increased demand and pressure on profitability due to the company's cost structure and …